Hypertension - treatment by blockade of the Renin-Angiotensin system

Pharmacochemistry Library

Volumn 28, Issue C, 1997, Pages 97-107

  Greenlee, W J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1542302578     PISSN: 01657208     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0165-7208(97)80056-6     Document Type: Article

References (51)

1. Kitler M.E. Drugs and Aging 8 (1996) 5
2. Sytkowski P.A., D'Agostino R.B., Belanger A.J., and Kannel W.B. Circulation 93 (1996) 697
3. For a general reference, see. Hypertension: Pathophysiology, Diagnosis and Mangement. In: Laragh J.H., and Brenner B.M. (Eds) (1990), Raven Press, New York
4. For a recent review, see. Laragh J.H. In: Timmermans P.B.M.W.M., and Wexler R.R. (Eds). Medicinal Chemistry of the Renin-Angiotensin System (1994), Elsevier, Lausanne 1
5. For a recent review, see: D. McAreavey. Robertson J.I.S. Drugs 40 (1990) 326
6. July/August. Opie L.H. Scientific American Science and medicine (1994) 14
7. Os I., Bratland B., Dahlof B., Gisholt K., Syvertsen J.O., and Tretli S. Am. J. Hypertens. 7 (1994) 1012
8. Woo K.S., Norris R.M., and Nicholls G. Am. J. Cardiology 75 (1995) 967
9. For recent reviews see:. Rosenberg S.H., and Boyd S.A. in press. In: Van Zwieten P.A., and Greenlee W.J. (Eds). Antihypertensive Drugs (1997), Harwood, London
10. (b) P. Raddatz, Exp. Opin. Ther. Pat., 4 (1994), 489.
11. Hoover D.J., Lefker B.A., Rosati R.R., Wester R.T., Kleinman E.F., Bindra J.S., Holt W.F., Murphy W.R., Mangiapane M.L., Hockel G.M., Williams I.H., Smith W.H., Gumkowski M.J., Shepard R.M., Gardner M.J., and Nocerini M.R. In: Takahashi K. (Ed). Aspartic Proteinases, Structure, Function, Biology and Biomedical Implications (1995), Plenum Press, New York 167
12. Rasetti V., Cohen N.C., Rueger H., Goeschke R., Maibaum J., and Cumin F. Bioorg. Med. Chem. Lett. 6 (1996) 1589
13. For recent reviews see. Wexler R.R., Greenlee W.J., Irvin J.D., Goldberg M.R., Prendergast K., Smith R.D., and Timmermans P.B.M.W.M. J. Med. Chem. 39 (1996) 625
14. in press. Levin J.I. In: Van Zwieten P.A., and Greenlee W.J. (Eds). Antihypertensive Drugs (1997), Harwood Publishers, London
15. Y. Furukawa, S. Kishimoto and K. Nishikawa, U. S. Patents 4,340,598 and 4,355,040, 1982.
16. Duncia J.V., Carini D.J., Chiu A.T., Johnson A.L., Price W.A., Wong P.C., and Wexler R.R. Med. Res. Rev. 12 (1992) 149
17. Christen Y., Waeber B., Nussberger J., Porchet M., Borland N., Lee R., Maggon K., Shum L., Timmermans P., and Brunner H. Circulation 83 (1991) 1333
18. Cockcroft J., Sciberras D., Goldberg M., and Ritter J. J. Cardiovasc. Pharmacol. 22 (1993) 579
19. Goldberg M., Bradstreet T., McWilliams E., Tanaka W., Lipert S., Bjornsson T., Waldman S., Osborne B., Pivadori L., Lewis G., Blum R., Herman T., Abraham P., Halstenson C., Lo M.-W., Lu H., and Spector R. Hypertension 25 (1995) 37
20. Gradman A., Arcuri K., Goldberg A., Ikeda L., Nelson E., Snavely D., and Sweet C. Hypertension 25 (1995) 1345
21. Muller P., Cohen T., de Gasparo M., Sioufi A., Racine Poon A., and Howard H. Eur. J. Clin. Pharmacol. 47 (1994) 231
22. Strodter D., Zerssig I., Heath R., and Federlm K. Nierer Hochdruckr 23 (1994) 217
23. Harb G., Morgan J.M., Prasad P., Byra W., Piraino A.J., Kapadia D., Hirschhorn W., McNutly P., Blazek L., and Liusi L. J. Invest. Med. 43 Suppl. 2 (1995) 293A
24. Hagmann M., Burnier M., Nussberger J., Leenhardt A.F., Brouard R., Waeber B., and Brunner H.R. Am. J. Hypertens. 7 (1994) 13A
25. Burnier M., Hagmann M., Nussberger J., Biollaz J., Armagnac C., Brouard R., Waeber B., and Brunner H.R. Hypertension 25 (1995) 602
26. Van der Meiracker A.H., Admiraal P.J.J., Janssen J.A., Kroodsma J.M., de Ronde W.A.M., Boomsma F., Sissman J., Blankestijn P.J., Mulder P.G.M., Manin't Veld A.J., and D.H. Schalekamp M.A. Hypertension 25 (1995) 22
27. Ilson B., Boike S., Audet P., Freed M., Everitt D., Brown L., Zariffa N., and Jorkasky D. Clin. Pharmacol. Ther. 55 (1994) 206
28. White W.B., Mansoor G.A., Lessem J., and Schusterman N. Clin. Res. 42 (1994) 447A
29. Ogihard T., Higashimori K., Masuo K., and Mikami H. Clin. Ther. 15 (1993) 684
30. Delacretaz E., Nussberger J., Biollaz J., Waeber B., and Brunner H.R. Hypertension 25 (1995) 14
31. Su C.A.P.F., Van Heiningen P.N.M., Van Lier J.J., Bruin H.D., Kirchgassler K.U., Cornelissen P.J.G., and Jonkman J.H.G. Clin. Pharmacol. Ther. 55 (1994) 205
32. Steinhauslin F., Buclin T., Bouissou P., Verejan I., Nussberger J., Tournare P.H., Vadiei K., Brunneer H.R., and Biollaz J. Clin. Pharmacol. Ther. 55 (1994) 205
33. 2 antagonists, see:. Hodges J.C. Exp. Opin. Ther. Pat. 4 (1994) 1325
34. Blankley C.J., and Sircar I. In: Timmermans P.B.M.W.M., and Wexler R.R. (Eds). Medicinal Chemistry of the Renin-Angiotensin System (1994), Elsevier, Amsterdam 347
35. Goldberg M.R., Tanaka W., Barchowsky A., Bradstreet T.E., McCrea J., Lo M.-W., Mc Williams E.J., and Bjornsson T.D. Hypertension 21 (1993) 704
36. For a recent review see:. Chang L.L., and Greenlee W.J. Current Pharmaceutical Design 1 (1995) 407
37. Zhang J., Entzeroth M., Wienen W., and Van Meel J.C.A. Eur. J. Pharmacol. 218 (1992) 35
38. de Laszlo S.E., Quagliato C.S., Greenlee W.J., Patchett A.A., Chang R.S.L., Lotti V.J., Chen T.B., Scheck S.A., Faust K.A., Kivlighn S.D., Schorn T.S., Zingaro G.J., and P.K.S. J. Med. Chem. 36 (1993) 3207
39. Chang R.S.L., Lotti V.J., Chen T.-B., Faust K.A., Kling P.J., O'Malley S.A., Kivlighn S.D., Siegl P.K.S., Ondeyka D., Greenlee W.J., and Mantlo N.B. Eur. J. Pharmacol. 294 (1995) 429
40. Kivlighn S.D., Zingaro G.J., Gabel R.A., Broten T.P., Chang R.S.L., Ondeyka D.L., Mantlo N.B., Gibson R.E., Greenlee W.J., and Siegl P.K. Eur. J. Pharmacol. 294 (1995) 439
41. Wong P.C., Quan M.L., Haij-Ali A.F., Saye J.M., Bernard R., Crain E.J., McCall D.E., Watson C.A., Zaspel A.M., Smith R.D., and Wexler R.R. J. Cardiovasc. Pharmacol. 26 (1995) 354
42. Deprez P., Guillaume J., Corbier A., Vevert J.-P., Fortin M., and Heckmann B. Bioorg. Med. Chem. Lett. 5 (1995) 2617
43. Kivlighn S.D., Zingaro G.J., Rivero R.A., Huckle W.R., Lotti V.J., Chang R.S.L., Schorn T.W., Kevin N., Johnson Jr. R.G., Greenlee W.J., and Siegl P.K.S. Am. J. Physiol. 268 (1995) R820
44. Perlman S., Schambye H.T., Rivero R.A., Greenlee W.J., Hjorth S.A., and Schwartz T.W. J. Biol. Chem. 370 (1995) 1493
45. Huckle W.R., Kivlighn S.D., Zingaro G.J., Kevin N., Rivero R.A., Chang R.S., Greenlee W.J., Siegl P.K.S., and Johnson R.G. Can. J. Physiol. Pharmacol. 72 Suppl. 1 (1994) 543
46. Kaye A.D., Nossaman B.D., Kivlighn S., Ibrahim I.N., De Witt B.J., and Kadowitz P.J. Eur. J. Pharmacol. 287 (1995) 163
47. Shinagawa T., Do Y.S., Baxter J.S., Carilli C., Schilling J., and Hseuh W.A. Proc.Natl.Acad. Sci.USA 28 (1990) 1927
48. Kitami Y., Hiwada K., Murakami E., Muneta S., and Kokubu T. J. Hypertens. 8 (1990) 1143
49. Urata H., Boehm K.D., Philip A., Kinoshita A., Gabrovsek J., Bumpus F.M., and Husain A. J. Clin. Invest. 91 (1993) 1269
50. D. J. Hoover, European Patent Application (PCT), WO 93/25574 (1993).
51. F. Akahosi, T. Yoshimura, M. Eda, A. Ashimori, H. Fukuyama, et al., European Patent Application (PCT), WO 96/33974 (1996).